STOCK TITAN

Identity, Security & Access Control (IDaaS) Solutions Provider BIO-key Hosts Q4 Investor Call Tuesday, March 29th at 10am ET

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

BIO-key International, Inc. (NASDAQ: BKYI) will discuss its fourth quarter and full year 2021 results during a conference call on March 29, 2022, at 10 a.m. ET. The call will feature key executives including Chairman & CEO Mike DePasquale and CFO Cecilia Welch. Results will be available before market opening on the same day. The company emphasizes its role in identity and access management through innovative biometric solutions. Investors can access the call via dial-in or a live webcast.

Positive
  • Upcoming conference call to discuss fourth quarter and full year 2021 results, indicating transparency.
  • Participation of key executives underscores commitment to engaging with investors.
Negative
  • None.

WALL, N.J., March 16, 2022 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) and large-scale identity solutions, will review its fourth quarter and full year 2021 results in a conference call Tuesday, March 29, 2022 at 10 a.m. ET. Results will be released before the market opens that morning. Mike DePasquale, Chairman & CEO; Cecilia Welch, CFO; Kimberly Johnson, VP of Product; and Alex Rocha, President, BK EMEA (Europe, Middle East, Africa) will participate on the call.

Conference Call Details
Date / Time:Tuesday, March 29th at 10 a.m. ET
Call Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 International
Live Webcast / Replay:Investor Webcast & Replay – Available for 3 months.
Audio Replay:1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 8157908

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including PortalGuard that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premises and Identity-as-a-Service (IDaaS) solutions as well as customized enterprise and cloud solutions.

Engage with BIO-key
Facebook – Corporate:https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate:https://www.linkedin.com/company/bio-key-international
Twitter – Corporate:@BIOkeyIntl
Twitter – Investors:@BIO_keyIR
StockTwits:BIO_keyIR


Media ContactInvestor Contact
Erin KnappWilliam Jones, David Collins
Matter CommunicationsCatalyst IR
BIO-key@matternow.comBKYI@catalyst-ir.com
914-260-3158212-924-9800

 


FAQ

What will BIO-key discuss in the March 29, 2022, conference call?

BIO-key will review its fourth quarter and full year 2021 financial results.

Who will be speaking on the BIO-key conference call?

Key executives including Mike DePasquale (Chairman & CEO) and Cecilia Welch (CFO) will participate.

When will BIO-key release its Q4 2021 results?

Results will be released before the market opens on March 29, 2022.

How can I access the BIO-key conference call?

The call can be accessed via dial-in or a live webcast.

What time is the BIO-key conference call scheduled for?

The conference call is scheduled for March 29, 2022, at 10 a.m. ET.

BIO-key International, Inc.

NASDAQ:BKYI

BKYI Rankings

BKYI Latest News

BKYI Stock Data

2.63M
2.93M
5.58%
9.26%
27.83%
Security & Protection Services
Services-prepackaged Software
Link
United States of America
HOLMDEL